首页 | 官方网站   微博 | 高级检索  
     

凯时治疗重型肝炎高胆红素血症疗效观察
引用本文:刘少伟,黄永华,彭利琼,林彩银. 凯时治疗重型肝炎高胆红素血症疗效观察[J]. 国际医药卫生导报, 2007, 13(9): 70-71
作者姓名:刘少伟  黄永华  彭利琼  林彩银
作者单位:五华县人民医院,广东五华,514400;五华县人民医院,广东五华,514400;五华县人民医院,广东五华,514400;五华县人民医院,广东五华,514400
摘    要:目的 探讨凯时(前列腺素E1)对重型肝炎高胆红素血症的疗效.方法 67例患者随机分为两组,对照组(B组)30例常规护肝药治疗;治疗组(A组)37例在对照组基础上加用凯时10ug,加入生理氯化钠溶液100ml静滴,qd,4周为1个疗程.结果 治疗组TBil与ALT比对照组明显下降,有显著性差异(P<0.05).治疗组的总有效率(显效 有效)显著高于对照组(P<0.05).结论 凯时对重型肝炎高胆红素血症有较好的疗效.

关 键 词:前列腺素·E1  重型肝炎  胆红素
文章编号:1007-1245(2007)09-0070-02
修稿时间:2007-03-19

Mordechai Observed Treatment of Severe Hepatitis Hyperbilirubinemia
LIU Shaowei,HUANG Yonghua,PENG Liqiong,LIN Caiyin. Mordechai Observed Treatment of Severe Hepatitis Hyperbilirubinemia[J]. International Medicine & Health Guidance News, 2007, 13(9): 70-71
Authors:LIU Shaowei  HUANG Yonghua  PENG Liqiong  LIN Caiyin
Abstract:Objective Mordechai(PGE1),the effect of severe hepatitis hyperbilirubinemia. Methods 67 patients were randomly divided into two groups:the control group(group B) 30 cases Hugan conventional treatment;treatment group(A) 37 cases in the control group based on the use of Mordechai 10ug. Infusion of 100 ml of physiological NaCl solution,qd,for one course of four weeks. Results TBil ALT in the treatment group compared with the control group decreased significantly(P <0.05). The total efficiency of the treatment group(effective biological ) was significantly higher(P <0.05). Mordechai Conclusion of severe hepatitis hyperbilirubinemia a better effect.
Keywords:Prostaglandin E1 Severe hepatitis Bilirubin
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号